FDA Approves First IV Migraine Prevention Drug FDA Approves First IV Migraine Prevention Drug

The FDA has approved eptinezumab-jjmr, the first intravenous drug for migraine prevention.FDA Approvals

Source: Medscape Internal Medicine Headlines - February 24, 2020 Category: Internal Medicine Tags: Neurology & Neurosurgery News Alert Source Type: news